Document 0030 DOCN M9550030 TI Survival of MHC-deficient mouse heterotopic cardiac allografts. DT 9505 AU Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF; Department of Surgery, Hospital of the University of; Pennsylvania, Philadelphia 19104. SO Transplantation. 1995 Jan 27;59(2):187-91. Unique Identifier : AIDSLINE MED/95141380 AB The immunologic mechanisms involved in the destruction of murine cardiac allografts were evaluated using MHC-deficient mice. Specifically, we examined the survival of immediately vascularized heterotopic adult cardiac grafts deficient in MHC class I, MHC class II, or both MHC class I and II antigens following transplantation to allogeneic hosts. We observed indefinite cardiac graft survival when donors lacked MHC class II or both MHC I and II antigens. In parallel experiments, we studied the survival of cardiac grafts harvested from normal donors in recipients severely depleted of either CD4 (class II-deficient mice) or CD8 (class I-deficient mice) T cells. Graft survival was dramatically prolonged in the absence of CD4 but not CD8 T cells. Collectively, our results demonstrate that the interaction of host CD4 T cells with donor class II antigens is critical to the rejection of murine cardiac grafts. DE Animal Coronary Vessels/PHYSIOLOGY CD8-Positive T-Lymphocytes/IMMUNOLOGY Graft Survival/*IMMUNOLOGY Haplotypes Heart Transplantation/*IMMUNOLOGY Histocompatibility Antigens Class I/IMMUNOLOGY Histocompatibility Antigens Class II/IMMUNOLOGY/METABOLISM Lymphocyte Transformation/IMMUNOLOGY Major Histocompatibility Complex/*IMMUNOLOGY Mice Mice, Inbred Strains Neck Support, U.S. Gov't, P.H.S. T-Lymphocytes/IMMUNOLOGY Transplantation, Heterologous *Transplantation, Heterotopic Transplantation, Homologous JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).